History of the BIH
Reorganizing health research in Germany: that's what the then Federal Research Minister Annette Schavan had in mind when she founded the German Centers for Health Research in 2009.
Here, research into major widespread diseases - from cancer to cardiovascular diseases to infections - was to be integrated and strategically developed. The next step was to create a lighthouse in Berlin, the German capital, to reshape collaboration between university and non-university research. Schavan's colleague in the Berlin Senate, Jürgen Zöllner, supported the "Berlin Institute of Health" project, not least thanks to the generous donation from Johanna Quandt. The Charité, as the joint university medicine of Humboldt University and Freie Universität, was set as a partner on the clinical side; there were already connections to the MDC as an excellent center in basic research, which the BIH, founded in 2013, strengthened and expanded: Thus, translational medicine was anchored in the city of Berlin and also promoted throughout Germany.
BIH History Leporello
|The Founding Supervisory Board holds its constitutive meeting.
|Evaluation of Scientific Concept
|An international evaluation commission presents its assessment of the new institution’s scientific concept. The assessment is highly positive.
|The Head Office begins its work.
|On the basis of the scientific concept joint project groups formed by the Charité and MDC develop implementation plans for the research program.
|The members of the Scientific Advisory Board are nominated.
|A first funding call (for Collaborative Research Grants) is published.
|The Directorate develops the research and budget plan with detailed measures and milestones.
|The Scientific Advisory Board meets for its founding session.
|The first Collaborative Research projects begin their activities.
|The first pathfinder studies are chosen at the CRU.
|The first BIH professorship "Experimentelle Herz-Kreislaufforschung" is being established.
|The Berlin House of Representatives passes the "Gesetz zur Errichtung des Berliner Instituts für Gesundheitsforschung" (Legislation for the formation of the Berlin Institute of Health).
|The legislation enabling the formation of the Berlin Institute of Health is passed into effect.
|BIH operates as independent corporation under public law
|Supervisory Board approves “BIH Strategy 2026”
|Supervisory Board approves “Strategy Implementation Plan 2017–2020”
|The Digital Health Accelerator of the BIH is founded.
|The first BIH Johanna Quandt Professor Petra Ritter is appointed.
|Opening of the BIH QUEST Center with BIH Chair Ulrich Dirnagl.
|Opening of BIH Digital Health Center with BIH Chair Roland Eils.
|DFG supports Digital Clinician Scientist Program as an innovative career path of the BIH Academy.
|EU supports RESTORE project of BIH Regeneration with 1 Mio Euro.
|BIH Chair Christof von Kalle heads the Center for Clinical Studies of BIH and Charité.
|The Government and the State of Berlin sign the administrative agreement on the integration of the BIH into the Charité - Universitätsmedizin Berlin.
|Foundation of the new research focus Single Cells.
|BIH leads the BMBF-funded project CORD-MI (Collaboration on Rare Diseases) with almost 6 million euros.
|BIH Professor and Director of the Institute of Virology at Charité Christian Drosten receives "Special Award for Outstanding Communication of Science in the COVID-19 Pandemic".
|Symbolic topping-out ceremony at the ATIZ - the joint Outpatient, Translational and Innovation Center of BIH and Charité.
|Professor Christopher Baum becomes Chairman of the Board of BIH.
|Professor Georg Duda becomes BIH Chair for Engineering Regenerative Therapies.
|BIH becomes translational research area and third pillar of Charité - Universitätsmedizin Berlin. The MDC becomes a Privileged Partner of BIH.